These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13156535)

  • 1. [Recent concepts of the etiology and therapy of arteriosclerosis with special reference to heparin].
    THURNHERR A; NIEDERBERGER W
    Schweiz Med Wochenschr; 1954 Mar; 84(10):285-90. PubMed ID: 13156535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipoprotein studies on the etiology of arteriosclerosis; with a special reference to paper electrophoretic lipoprotein determination and heparin therapy].
    THURNHERR A; NIEDERBERGER W
    Bull Schweiz Akad Med Wiss; 1956 Apr; 12(1):1-20; discussion, 21-2. PubMed ID: 13316344
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical results of lipocaic-heparin mixture in arteriosclerotic patients and physico-chemical modifications of blood lipoproteins].
    BONO F; CORTINOVIS R
    Minerva Chir; 1955 Jul; 10(14):685-8. PubMed ID: 13279621
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of heparin in atherosclerosis; clinical and experimental study].
    FRANCO A
    Med Contemp; 1954 Nov; 72(11):535-51. PubMed ID: 13234993
    [No Abstract]   [Full Text] [Related]  

  • 5. [The physiopathology of heparin; variations in the cholesterol/heparin quotient during heparin therapy].
    PESCADOR L; OUTEIRINO J; SAINZ V
    Rev Clin Esp; 1955 Jan; 56(2):94-6. PubMed ID: 14385222
    [No Abstract]   [Full Text] [Related]  

  • 6. [Perlingual heparin therapy of atheroma].
    MONGIN M; FREDENUCCI M
    Mars Med; 1959; 96(3):157-67. PubMed ID: 13655923
    [No Abstract]   [Full Text] [Related]  

  • 7. [Heparin treatment of arteriosclerosis].
    KELLER R
    Medizinische; 1954 Jul; 29-30():995-8. PubMed ID: 13185034
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of oral heparin in the treatment and prevention of arteriosclerosis].
    ALBRIEUX AS; ROCCA FF; ESTEFAN JC
    Dia Med; 1957 Jan; 29(1):26-8. PubMed ID: 13414560
    [No Abstract]   [Full Text] [Related]  

  • 9. [Heparin activity and plasmatic lipoproteins in arteriosclerosis].
    GUTIERREZ VALLEJO F; INFANTE MIRANDA R
    Angiologia; 1957; 9(3):131-4. PubMed ID: 13435528
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with the administration of heparin in patients with cerebral arteriosclerosis].
    KECOVA H
    Cas Lek Cesk; 1957 Feb; 96(7):193-8. PubMed ID: 13413918
    [No Abstract]   [Full Text] [Related]  

  • 11. [Heparin and arteriosclerosis].
    SOLIGNAC H
    Fr Med; 1953 Jun; 16(6):21-5. PubMed ID: 13095613
    [No Abstract]   [Full Text] [Related]  

  • 12. [Small doses of intra-arterial heparin in therapy of some peripheral arterial diseases].
    BUTTO M; MASETTO I
    Acta Med Patav; 1954; 14(2):281-92. PubMed ID: 13217714
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of heparin in the treatment of foveal processes due to atherosclerosis].
    STARK H
    Klin Monbl Augenheilkd Augenarztl Fortbild; 1957; 131(2):165-78. PubMed ID: 13482174
    [No Abstract]   [Full Text] [Related]  

  • 14. [The disturbances of blood lipo-proteins and their correction by heparin in atherosclerosis].
    RAYNAUD R; D'ESHOUGUES JR; PASQUET P
    Alger Medicale; 1952 Feb; 56(2):75-82. PubMed ID: 14952426
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoelectrodiffusional determination of beta-lipoproteins in the plasma of heparin-treated patients.
    Tinterova Z; Ognianov M
    Clin Chim Acta; 1969 Dec; 26(3):583. PubMed ID: 5358560
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent concepts on arteriosclerosis seen in special correlation to lipoprotein particles].
    Malcolm J; Hunt P
    Brux Med; 1971 Jan; 51(1):43-56. PubMed ID: 5549727
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relation between heparin in repeated doses & intensity of the clearing. effect in healthy & arteriosclerotic subjects; potentiation of this effect in atherosclerotics by gastric mucin].
    ROSSI B; RULLI V
    Gazz Med Ital; 1959 May; 118(5):202-4. PubMed ID: 13664059
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heparin and the clearing reaction in atherosclerosis].
    ZEMPLENYI T; FELT V; FODOR J; REICHL D; PILAR J
    Cas Lek Cesk; 1955 Mar; 94(10):262-66. PubMed ID: 14364539
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hypertension with heparin].
    CHIARI M; STEMBERGER T
    Wien Klin Wochenschr; 1957 Nov; 69(45):854-6. PubMed ID: 13530977
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiatheromatous properties of heparin: objective clinical and biological].
    TAMCHES A
    Presse Med (1893); 1953 Oct; 61(68):1382. PubMed ID: 13112166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.